MacGuire Cheswick & Tuttle Investment Counsel’s Amgen AMGN Stock Holding History

MacGuire Cheswick & Tuttle Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$248K	Hold	1,275	–	–	0.05%	86
2018 Q3	$264K	Hold	1,275	–	–	0.05%	89
2018 Q2	$235K	Hold	1,275	–	–	0.04%	91
2018 Q1	$217K	Hold	1,275	–	–	0.04%	96
2017 Q4	$222K	Hold	1,275	–	–	0.04%	93
2017 Q3	$238K	Hold	1,275	–	–	0.05%	92
2017 Q2	$220K	Hold	1,275	–	–	0.04%	90
2017 Q1	$209K	Buy	+1,275	New	+$212K	0.04%	87
2016 Q4	–	Sell	-1,275	Closed	-$213K	–	91
2016 Q3	$213K	Buy	+1,275	New	+$216K	0.05%	82
2016 Q1	–	Sell	-1,275	Closed	-$207K	–	91
2015 Q4	$207K	Buy	+1,275	New	+$200K	0.05%	88
2015 Q2	–	Sell	-1,275	Closed	-$204K	–	95
2015 Q1	$204K	Hold	1,275	–	–	0.05%	95
2014 Q4	$203K	Buy	+1,275	New	+$199K	0.05%	97

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MacGuire Cheswick & Tuttle Investment Counsel's AMGN Position: Q4 2018 in Review

MacGuire Cheswick & Tuttle Investment Counsel held its Amgen (AMGN) position steady in Q4 2018 at 1,275 shares worth $248K. The position accounts for 0.05% of the portfolio, ranked #86.

MacGuire Cheswick & Tuttle Investment Counsel first reported a position in AMGN in Q4 2014 and has held it in 12 quarters since. The position peaked at $264K in Q3 2018. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

MacGuire Cheswick & Tuttle Investment Counsel held 1,275 shares of Amgen worth $248K as of Q4 2018.
MacGuire Cheswick & Tuttle Investment Counsel left its Amgen share count unchanged in Q4 2018.
Amgen made up 0.05% of MacGuire Cheswick & Tuttle Investment Counsel's portfolio in Q4 2018, its #86 holding.
MacGuire Cheswick & Tuttle Investment Counsel first reported a position in Amgen in Q4 2014 and has held it in 12 quarters since.
MacGuire Cheswick & Tuttle Investment Counsel's Amgen position peaked at $264K in Q3 2018.
1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on MacGuire Cheswick & Tuttle Investment Counsel's 13F filing for Q4 2018, filed 11 Feb 2019.